Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-metastatic Prostate Cancer × darolutamide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 44 Prostatic Neoplasms, Castration-Resistant 3 Urogenital Neoplasms 2 Salivary Gland Neoplasms 2 Prostatic Diseases 2 Non-metastatic Castration-resistant Prostate Cancer 2 Neoplasms 2 Neoplasm Metastasis 2 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2 Metastatic Castration-resistant Prostate Cancer 2 Male Urogenital Diseases 2 Bulbo-Spinal Atrophy, X-Linked 2 Biochemically Recurrent Prostate Cancer 2 Adenocarcinoma 2 Urogenital Diseases 1 Triple Negative Breast Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Prostate Adenocarcinoma 1 Neoplasms by Site 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 High-Risk Localized Prostate Cancer 1 Granulosa cell tumor of the ovary 1 Genital Diseases, Male 1 Fatigue 1 Depression 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡